ARS Pharmaceuticals (SPRY) Stock Sinks After-Hours After Commercial Update On Neffy Coverage - ARS Pharma

ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins - ARS Pharmaceuticals (

ARS Pharma reaffirmed its 2027 breakeven target, cut expenses and gained Florida Medicaid access for Neffy despite coverage setbacks.